Ειδήσεις: PHARMA | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

31/03 16:27 statnews.com

STAT+: Pharmalittle: We’re reading about pharma delaying launches in Europe, Lilly and Biogen deals, and more

pharma drug launches Europe U.S. pricing policy Lilly Biogen

31/03 15:54 yahoo.com

Immunic appoints biopharmaceutical executive Jon Congleton to board

Immunic Jon Congleton biopharmaceutical board appointment drug development regulatory affairs

31/03 15:40 statnews.com

STAT+: Psychedelic biotechs face scrutiny over YouTube promos

psychedelic biotechs YouTube promotions regulatory scrutiny pharma acquisitions Eli Lilly Biogen

31/03 15:32 marketwatch.com

Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug

Lilly narcolepsy drug $7.8B acquisition GLP‑1 franchise dealmaker pharmaceutical acquisition

31/03 15:01 investing.com

Agios stock surges on FDA path for mitapivat approval

Agios Pharmaceuticals mitapivat FDA approval stock surge rare metabolic disorders investor confidence

31/03 14:34 yahoo.com

Is Collegium Pharmaceutical (COLL) One of the Best Small-Cap Drug Manufacturers

Collegium Pharmaceutical small‑cap drug manufacturer financial analysis pipeline regulatory milestones

31/03 14:34 yahoo.com

What Makes Bausch Health (BHC) Appear So Attractive

Bausch Health BHC pharmaceutical valuation pipeline cash flow

31/03 14:34 yahoo.com

Aquestive Therapeutics (AQST) Awaits Anaphylm NDA Approval in Q3

Aquestive Therapeutics AQST Anaphylm NDA approval anaphylaxis treatment FDA

31/03 14:29 statnews.com

STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal

Eli Lilly Centessa Pharmaceuticals acquisition narcolepsy drug $6.3B premium

31/03 14:29 statnews.com

STAT+: Eli Lilly to buy Centessa Pharmaceuticals, maker of a narcolepsy drug, in $6.3B deal

Eli Lilly Centessa Pharmaceuticals acquisition narcolepsy drug $6.3B premium

Loading...